Randa Hisham Aljorani

1PUBLICATIONS
2CO-AUTHORS
Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Apr 29, 2025
Ripasudil, a Rho kinase inhibitor, attenuates testosterone-induced benign prostatic hyperplasia in rats: targeting inflammation, oxidative stress, and Rho kinase pathways.

Randa Hisham Aljorani, Adeeb Ahmed Al-Zubaidy, Nibrass Taher Abdali

Pageof 1